FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

LALPATHLAB Share Price Target

Dr. Lal Pathlabs Ltd.
Sector: Pharmaceuticals and health care
... Read more
LALPATHLAB Share Price *
1,620.35 -45.9 (-2.75%)
* (quote may be delayed)
LALPATHLAB Share Price Forecast - Consensus
No. of reports in last year
4
No. of analysts
2
Average Consensus Forecast
1148.75
Consensus Potential
-45.73%

LALPATHLAB Share Price Target - Broker Reports - 2019

Karvy Stock Broking
23-Aug-19
Price @ Call: 1173
Target: 1285
HOLD
We downgrade the stock to a ‘HOLD’ rating and value Dr Lal PathLabs at 38x FY21E EPS of Rs. 33.8 for a target of Rs. 1285. Slower than expected penetration in Rest of North, East and Central India pose a threat to our call.
... Read more

Prabhudas Lilladher
14-Aug-19
Price @ Call: 1060.4
Target: 1120
ACCUMULATE
Q1 in line; Favorable product mix leads margin
DLPL’s revenue, adj. EBITDA and PAT grew 15%, 21% and 19% YoY respectively in Q1FY20 and in line with our estimates in margin and earnings. With strong cash flow and growth in new customers and packaged offer, the company expects to maintain current growth in FY20E. The expansion of bundle-test offer and gradual ramp up of central lab in Kolkata (KRL) to improve further volume addition in FY20E and FY21E. Management expects competitive intensity to remain strong with price war, regulatory interference and expected price ceiling of government. DLPL remain confident of its brand power, service quality, high-end test capability, network of collection centers and KRL to drive volume growth and profitability in FY19-21E. We maintain“Accumulate” and retain TP at Rs1,120.
... Read more

Prabhudas Lilladher
20-May-19
Price @ Call: 1044.4
Target: 1120
ACCUMULATE
Management expects competitive intensity to remain strong with price war, regulatory interference and an expected price ceiling from the government. DLPL remains confident of its brand power, service quality, high-end test capability, network of collection centers and KRL which will drive volume growth and profitability in FY20-21E. We maintain“Accumulate” and move forward our base of valuation to 32x of FY21E earnings estimates to derive new TP at Rs1,120 (from Rs1,009).
... Read more

Prabhudas Lilladher
12-Feb-19
Price @ Call: 1021.1
Target: 1070
ACCUMULATE

LALPATHLAB Share Price Target - Broker Reports - 2018

Prabhudas Lilladher
7-Nov-18
Price @ Call: 892.19
Target: 1009
ACCUMULATE

Kotak Securities
13-Aug-18
Price @ Call: 915.5
Target: 900
REDUCE

Edelweiss
15-May-18
Price @ Call: 887.2
Target: 1050
BUY

Prabhudas Lilladher
14-May-18
Price @ Call: 815.9
Target: 1009
ACCUMULATE

Edelweiss
12-Feb-18
Price @ Call: 903
Target: 1050
BUY

LALPATHLAB Share Price Target - Broker Reports - 2017

Prabhudas Lilladher
9-Nov-17
Price @ Call: 817.16
Target: 963
ACCUMULATE

Edelweiss
9-Aug-17
Price @ Call: 821.1
Target: 900
BUY

HDFC Securities
31-Mar-17
Price @ Call: 964.28
Target: 1162.5
BUY

Edelweiss
2-Feb-17
Price @ Call: 1082
Target: 1230
BUY

LALPATHLAB Share Price Target - Broker Reports - 2016

Edelweiss
3-Nov-16
Price @ Call: 1194
Target: 1230
BUY

Edelweiss
14-Oct-16
Price @ Call: 1036.5
Target: 1180
BUY

  • LALPATHLAB - Share Price Target Potential

    keyboard_arrow_down
    BrokerageTargetPotential
    Karvy Stock Broking1,285-29.67%
    Prabhudas Lilladher1,120-48.77%